On a background of overexpressed TLR7 in susceptible SLE patients, it is conceivable that overzealous production of type I IFN in response to mRNA in COVID-19 vaccination can drive disease activity and induce flares. The gene discussed is TLR7; the disease is systemic lupus erythematosus.